Loading…
Loading…
EQUITY / NASDAQ · XNCM
Clearmind Medicine Inc. Common Shares
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →11/01/2024 – 10/31/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.715 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 0.715 USD · Volume 98,383
21 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
11/01/2024 – 10/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Net income | -3,856,983 USD | -5,254,678 USD | — |
| Operating cash flow | -4,734,498 USD | -4,858,659 USD | — |
| Cash and cash equivalents | 3,923,058 USD | 6,573,813 USD | -40.32% |
| Total liabilities | 4,890,456 USD | 4,147,862 USD | +17.90% |
| Total equity | 1,192,596 USD | 3,107,552 USD | -61.62% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end11/01/2024 – 10/31/2025ConsolidatedUnits · USD | 2024 / Year end11/01/2023 – 10/31/2024ConsolidatedUnits · USD | 2023 / Year end11/01/2022 – 10/31/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 3,923,058 USD | 6,573,813 USD | 5,427,739 USD |
| Financing cash flowCash flow statement | 2,622,543 USD | 6,254,378 USD | 11,664,396 USD |
| Investing cash flowCash flow statement | -542,017 USD | -238,097 USD | -26,228 USD |
| Net incomeIncome statement | -3,856,983 USD | -5,254,678 USD | -8,620,837 USD |
| Operating cash flowCash flow statement | -4,734,498 USD | -4,858,659 USD | -6,301,472 USD |
| Total assetsBalance sheet | 6,083,052 USD | 7,255,414 USD | — |
| Total equityBalance sheet | 1,192,596 USD | 3,107,552 USD | 983,472 USD |
| Total liabilitiesBalance sheet | 4,890,456 USD | 4,147,862 USD | — |
| Report source | Open report ↗ Published: 01/20/2026 | Open report ↗ Published: 01/20/2026 | Open report ↗ Published: 01/20/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.